DANA MEADE: Open Payments
NPI 1780337162 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 42 payments from 14 companies in 2025. Trend: 2023 $220 · 2024 $645 · 2025 $1,714
Food & beverage: $1,015Travel & lodging: $699
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $794 |
| Novo Nordisk Inc | 4 | $168 |
| HEARTFLOW, INC. | 1 | $138 |
| Alnylam Pharmaceuticals Inc. | 6 | $115 |
| CVRx, Inc. | 1 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| PFIZER INC. | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: CARDIOMEMS, FFRct, Ozempic, Barostim Neo System, ONPATTRO, Kerendia, JARDIANCE, Wegovy.
Industry payments across CO — which companies pay providers there.
